Online citations, reference lists, and bibliographies.
← Back to Search

Principals Of Neovascularization For Tissue Engineering.

M. Nomi, A. Atala, P. Coppi, S. Soker
Published 2002 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
The goals in tissue engineering include the replacement of damaged, injured or missing body tissues with biological compatible substitutes such as bioengineered tissues. However, due to an initial mass loss after implantation, improved vascularization of the regenerated tissue is essential. Recent advances in understanding the process of blood vessel growth has offered significant tools for therapeutic neovascularization. Several angiogenic growth factors including vascular endothelial cell growth factor (VEGF) and basic fibroblast growth factor (bFGF) were used for vascularization of ischemic tissues. Three approaches have been used for vascularization of bioengineered tissue: incorporation of angiogenic factors in the bioengineered tissue, seeding endothelial cells with other cell types and prevascularization of matrices prior to cell seeding. This paper reviews the process of blood vessel growth and tissue vascularization, and discuss strategies for efficient vascularization of engineered tissues.
This paper references
10.1074/JBC.M009698200
Akt Down-regulation of p38 Signaling Provides a Novel Mechanism of Vascular Endothelial Growth Factor-mediated Cytoprotection in Endothelial Cells*
J. Gratton (2001)
10.1038/376070A0
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
T. Sato (1995)
10.1038/373699A0
Scatter factor/hepatocyte growth factor is essential for liver development
C. Schmidt (1995)
10.1126/SCIENCE.1312256
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.
C. de Vries (1992)
10.1007/978-3-0348-9006-9_1
Angiogenesis and angiogenesis inhibition: an overview.
J. Folkman (1997)
10.1023/A:1006708607666
Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor
M. Young (2004)
10.1056/NEJM199705223362106
Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada.
J. Tu (1997)
10.1161/01.CIR.100.18.1865
Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.
R. Laham (1999)
10.1007/978-3-642-59953-8_9
The angiopoietins: Yin and Yang in angiogenesis.
S. Davis (1999)
10.1002/j.1460-2075.1991.tb07836.x
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.
L. Naldini (1991)
10.1038/380435A0
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
P. Carmeliet (1996)
10.1016/S0142-9612(00)00120-4
Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering.
W. Murphy (2000)
10.1161/01.CIR.97.7.645
Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.
B. Schumacher (1998)
10.1016/0960-9822(93)90073-W
VEGF/VPF: The angiogenesis factor found?
M. Klagsbrun (1993)
10.1016/S0002-9149(98)00764-4
Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis.
J. Isner (1998)
Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.
E. Gherardi (1991)
10.1038/386671A0
Mechanisms of angiogenesis
W. Risau (1997)
10.1073/PNAS.90.5.1937
Scatter factor induces blood vessel formation in vivo.
D. Grant (1993)
10.1016/S0065-230X(08)60305-X
The FGF family of growth factors and oncogenes.
C. Basilico (1992)
10.1016/0006-291X(91)91924-2
Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture.
A. Morimoto (1991)
10.1074/JBC.270.22.13333
Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*)
A. Levy (1995)
10.1016/S1357-2725(01)00028-0
Neuropilin in the midst of cell migration and retraction.
S. Soker (2001)
10.1172/JCI117018
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.
S. Takeshita (1994)
10.1083/JCB.109.2.823
Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells
S. Rogelj (1989)
10.1038/35040568
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors
Jun Yamashita (2000)
10.1161/01.CIR.97.4.381
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
É. Van Belle (1998)
10.1038/83481
Continuous release of endostatin from microencapsulated engineered cells for tumor therapy
T. Joki (2001)
10.1210/EDRV.18.1.0292
Biological roles of fibroblast growth factor-2.
A. Bikfalvi (1997)
10.1016/0092-8674(91)90512-W
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
A. Yayon (1991)
10.1161/01.CIR.94.12.3291
Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.
T. Asahara (1996)
Proteolytic activation of hepatocyte growth factor in response to tissue injury.
K. Miyazawa (1994)
10.1091/MBC.4.12.1317
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.
J. Park (1993)
10.1016/S0092-8674(00)80108-7
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
D. Hanahan (1996)
10.1074/JBC.271.13.7788
The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*)
B. Keyt (1996)
10.1126/SCIENCE.1063889
Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function
K. Matsumoto (2001)
10.1007/PL00007070
Systems for therapeutic angiogenesis in tissue engineering
S. Soker (2000)
10.1128/MCB.20.19.7282-7291.2000
Isoforms of Vascular Endothelial Growth Factor Act in a Coordinate Fashion To Recruit and Expand Tumor Vasculature
J. Grunstein (2000)
10.1016/S0741-5214(95)70272-5
Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.
C. Bauters (1995)
10.1074/jbc.274.37.26141
Human Endothelial Cell Life Extension by Telomerase Expression*
J. Yang (1999)
10.1007/s001099900019
Molecular and biological properties of vascular endothelial growth factor
N. Ferrara (1999)
10.1073/PNAS.96.8.4536
Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain.
M. Mahoney (1999)
10.1161/01.RES.85.3.221
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.
T. Asahara (1999)
10.1074/jbc.271.5.2746
Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia (*)
A. Levy (1996)
10.1038/376066A0
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
G. Fong (1995)
10.1038/380439A0
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
N. Ferrara (1996)
10.1016/S0092-8674(00)81810-3
Blood Vessel Formation: What Is Its Molecular Basis?
J. Folkman (1996)
10.1038/7434
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
Tomono Takahashi (1999)
Transplantation of hepatocytes using porous, biodegradable sponges.
D. Mooney (1994)
10.1006/SCBI.1998.0091
VEGFs, receptors and angiogenesis.
T. Veikkola (1999)
10.1126/SCIENCE.277.5322.48
Signaling Vascular Morphogenesis and Maintenance
D. Hanahan (1997)
Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.
K. Plate (1993)
10.1097/00007890-199308000-00033
CELL TRANSPLANTATION OF GENETICALLY ALTERED CELLS ON BIODEGRADABLE POLYMER SCAFFOLDS IN SYNGENEIC RATS
J. Gilbert (1993)
10.1038/nbt1101-1029
Polymeric system for dual growth factor delivery
T. P. Richardson (2001)
10.1007/BF00192885
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
E. Battegay (2004)
10.1016/S0140-6736(89)92760-8
PLATELET-DERIVED GROWTH FACTOR
R. Ross (1989)
10.1038/9853
DNA delivery from polymer matrices for tissue engineering
L. Shea (1999)
10.1038/85655
Telomerized human microvasculature is functional in vivo
Jiwei Yang (2001)
10.1016/0142-9612(91)90107-L
Controlled and modulated release of basic fibroblast growth factor.
E. Edelman (1991)
10.1038/359843A0
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
D. Shweiki (1992)
10.1007/978-1-4612-3210-0
Peptide Growth Factors and Their Receptors I
新井 健一 (1991)
10.1038/nm0901-1035
Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo
S. Kaushal (2001)
10.7326/0003-4819-109-6-519_2
Inflammation: Basic Principles and Clinical Correlates
J. Gallin (1992)
10.1126/SCIENCE.2425435
Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor.
J. Abraham (1986)
10.1073/PNAS.150242297
In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse.
J. Schechner (2000)
10.1111/j.1749-6632.1998.tb10115.x
Morphogenesis of the First Blood Vessels
C. Drake (1998)
10.1016/S0092-8674(00)81402-6
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
S. Soker (1998)
10.1002/BIT.260420606
Prevascularization of porous biodegradable polymers
A. Mikos (1993)
10.1016/S0140-6736(96)03361-2
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
J. Isner (1996)
10.1074/jbc.271.41.25492
Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau Protein*
A. Levy (1996)
10.1038/8462
Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon
T. Eto (1999)
10.1038/8379
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
P. Carmeliet (1999)
10.1007/BF03401749
Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease
A. Rivard (1998)
10.1016/S0093-7754(01)90021-1
Angiogenesis-dependent diseases.
J. Folkman (2001)
Molecular cloning of murine FLT and FLT4.
H. Finnerty (1993)
Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo.
S. Takeshita (1996)
10.1083/JCB.119.3.629
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
F. Bussolino (1992)
10.1084/JEM.174.5.1275
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels
H. Dvorak (1991)
10.1038/376062A0
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
F. Shalaby (1995)
10.1096/FASEBJ.12.1.47
A completely biological tissue-engineered human blood vessel.
N. L'heureux (1998)
10.1093/emboj/18.14.3964
VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells
T. Asahara (1999)
10.1172/JCI6127
Blood vessel maturation: vascular development comes of age.
D. Darland (1999)
Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable.
R. Furlong (1991)
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
K. Houck (1992)
10.1016/S0002-9394(14)75794-0
Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy
A. P. Adamis (1994)
10.1073/PNAS.83.19.7216
Structural evidence that endothelial cell growth factor beta is the precursor of both endothelial cell growth factor alpha and acidic fibroblast growth factor.
W. Burgess (1986)
10.1172/JCI116450
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.
D. Shweiki (1993)
10.1038/35040684
Developmental biology: One cell, two fates
P. Carmeliet (2000)
10.1126/SCIENCE.2934816
A blood vessel model constructed from collagen and cultured vascular cells.
C. B. Weinberg (1986)
10.1159/000236988
Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
H. Dvorak (1995)
10.1074/JBC.270.21.12607
Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes.
S. Frank (1995)
10.1038/373702A0
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
Y. Uehara (1995)
10.1126/SCIENCE.284.5413.489
Functional arteries grown in vitro.
L. Niklason (1999)
10.1126/SCIENCE.2479987
Vascular permeability factor, an endothelial cell mitogen related to PDGF.
P. J. Keck (1989)
10.1126/SCIENCE.275.5302.964
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
T. Asahara (1997)
10.1016/0741-5214(92)90106-I
Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor.
R. Baffour (1992)
10.1016/0022-3468(95)90610-X
Human hepatocyte isolation and transplantation into an athymic rat, using prevascularized cell polymer constructs.
M. Fontaine (1995)
10.1016/S0002-9440(10)65284-4
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.
J. Nör (1999)
10.1038/labinvest.3780252
In Vitro Models of Vasculogenesis and Angiogenesis
B. Vailhé (2001)
10.1074/jbc.271.10.5761
Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*)
S. Soker (1996)
10.1016/S1359-6101(96)00048-2
Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity.
M. Pepper (1997)
10.1089/10763270152044198
Establishment of heterotropic liver tissue mass with direct link to the host liver following implantation of hepatocytes transfected with vascular endothelial growth factor gene in mice.
I. Ajioka (2001)
10.1016/0092-8674(91)90363-4
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
R. Montesano (1991)
10.1126/SCIENCE.1382313
Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor.
A. Yanagisawa-Miwa (1992)
10.1073/PNAS.97.7.3422
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.
C. Kalka (2000)
10.1007/s003450050015
Tissue engineering from Adam to the zygote: historical reflections
D. Schultheiss (2000)
10.1016/S0889-8529(05)70324-8
The cellular and molecular mechanisms of diabetic complications.
G. King (1996)
10.1016/0006-291X(92)90483-2
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
B. Terman (1992)
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.
G. Breier (1992)
10.1016/S0741-5214(94)70135-0
Varicose veins and telangiectasias
S. Darke (1994)
10.1172/JCI9087
Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.
G. Schatteman (2000)
Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles.
W. Jiang (1997)
10.1038/35025215
Vascular-specific growth factors and blood vessel formation
G. Yancopoulos (2000)
The role of angiogenesis in tumor growth.
J. Folkman (1992)
10.1038/342440a0
Molecular cloning and expression of human hepatocyte growth factor
T. Nakamura (1989)
10.1016/S1097-2765(00)80154-9
VEGF gene delivery to muscle: potential role for vasculogenesis in adults.
M. Springer (1998)
10.1136/bmj.318.7197.1536
Therapeutic angiogenesis
T. Henry (1999)
10.1126/SCIENCE.1064344
Induction of Pancreatic Differentiation by Signals from Blood Vessels
E. Lammert (2001)
10.1038/labinvest.3780253
Engineering and Characterization of Functional Human Microvessels in Immunodeficient Mice
J. Nör (2001)
10.1046/J.1365-2168.1998.00765.X
Long‐term results of femorotibial bypass with vein or polytetrafluoroethylene
R. Sayers (1998)
10.1016/S0092-8674(00)81426-9
Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border
G. Yancopoulos (1998)
10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C
Molecular mechanisms of vasculogenesis and embryonic angiogenesis
I. Flamme (1997)
10.1007/BF03401566
Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen
D. Shima (1995)
10.1038/8374
Therapeutic angiogenesis for heart failure
J. Isner (1999)
10.1152/AJPCELL.2001.280.6.C1358
Role of vascular endothelial growth factor in regulation of physiological angiogenesis.
N. Ferrara (2001)
10.1038/nbt1101-1019
Growing better blood vessels
P. Carmeliet (2001)
Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.
M. Shibuya (1990)
10.1016/0092-8674(91)90173-V
A dual receptor system is required for basic fibroblast growth factor activity
M. Klagsbrun (1991)
10.1096/fasebj.12.13.1267
Interactions between scatter factors and their receptors: hints for therapeutic applications
L. Trusolino (1998)
10.1021/bp970135h
Development of Technologies Aiding Large‐Tissue Engineering
P. Eiselt (1998)
10.1038/SCIENTIFICAMERICAN0499-60
Growing new organs.
D. Mooney (1999)
10.1016/0955-2235(91)90014-U
Structure and function of hepatocyte growth factor.
T. Nakamura (1991)



This paper is referenced by
10.1007/S12376-009-0008-6
Regenerative Medicine: Past and Present
A. Atala (2009)
10.1111/j.1442-2042.2007.01768.x
Changing concepts of bladder regeneration
A. Kanematsu (2007)
10.1002/9781119044901.CH8
Polymer Modifications and Recent Technological Advances toward Live Cell Encapsulation and Delivery
Paulomi Ghosh (2015)
10.1007/s00441-014-2026-2
Vascularization of engineered cartilage constructs in a mouse model
M. Burghartz (2014)
10.1089/TEN.2006.12.1903
Small molecule inducers of angiogenesis for tissue engineering.
Kristen A. Wieghaus (2006)
10.1016/S0070-2153(04)61005-2
Advances in tissue engineering.
S. Levenberg (2004)
10.1201/b11625-39
Novel microspheres for prolonged cell survival
S. M. Ng (2012)
10.1097/01.prs.0000436839.62128.3b
Analysis of Fat Graft Metabolic Adaptation and Vascularization Using Positron Emission Tomography–Computed Tomographic Imaging
Tomi V. Tervala (2014)
10.1371/journal.pone.0046842
Endothelial Differentiation of Mesenchymal Stromal Cells
Karolina Janeczek Portalska (2012)
10.1016/j.actbio.2016.07.045
Hypoxia-mimicking Co doped TiO2 microporous coating on titanium with enhanced angiogenic and osteogenic activities.
Jianhong Zhou (2016)
10.2174/1574888X13666181105145144
Stem Cell-Mediated Angiogenesis in Tissue Engineering Constructs.
N. Kiaie (2019)
10.1007/s10439-018-02170-4
Harnessing Macrophages for Vascularization in Tissue Engineering
Erika M Moore (2018)
10.2217/nnm.10.12
Engineering hydrogels as extracellular matrix mimics.
Hikmet Geçkil (2010)
10.1021/ACSBIOMATERIALS.7B00025
Flow-Induced Vascular Network Formation and Maturation in Three-Dimensional Engineered Tissue
B. Zohar (2017)
10.1109/ISIE.2007.4375057
Microfabrication of Capillary System Using a Perfusion Cell Chamber
A. Migliore (2007)
10.1016/J.BIOMATERIALS.2007.07.003
Oxygen producing biomaterials for tissue regeneration.
B. Harrison (2007)
10.1016/j.biomaterials.2009.08.014
Reversible mitotic and metabolic inhibition following the encapsulation of fibroblasts in alginate hydrogels.
N. Hunt (2009)
10.1016/B978-1-78242-301-0.00002-1
Cells for musculoskeletal tissue engineering
K. Kong (2015)
10.3389/fbioe.2015.00117
Use of Mesothelial Cells and Biological Matrices for Tissue Engineering of Simple Epithelium Surrogates
C. C. Lachaud (2015)
10.3390/ijms19010286
Tissue Engineering to Improve Immature Testicular Tissue and Cell Transplantation Outcomes: One Step Closer to Fertility Restoration for Prepubertal Boys Exposed to Gonadotoxic Treatments
Federico Del Vento (2018)
10.1007/S00120-004-0702-7
[Biological vascularized matrix (BioVaM): a new method for solving the perfusion problems in tissue engineering].
D. Schultheiss (2004)
10.1016/J.UROLOGY.2005.01.054
Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation.
M. Youssif (2005)
10.1016/J.JBIOTEC.2005.03.016
VEGF profiling and angiogenesis in human microtissues.
J. Kelm (2005)
10.1109/WIO.2011.5981465
Non-destructive real-time imaging of cell morphology for tissue-engineering applications
M. Hofmann (2011)
10.1088/1748-6041/3/1/015007
Biocompatibility studies of endothelial cells on a novel calcium phosphate/SiO2-xerogel composite for bone tissue engineering.
Benjamin W. Thimm (2008)
10.1007/8415_2011_111
Mechanobiological Modelling of Angiogenesis: Impact on Tissue Engineering and Bone Regeneration
E. Reina-Romo (2011)
10.1097/SAP.0b013e3182573827
VEGF Microsphere Technology to Enhance Vascularization in Fat Grafting
Christopher W. Chung (2012)
10.1371/journal.pone.0035422
Endothelial Differentiation of Human Stem Cells Seeded onto Electrospun Polyhydroxybutyrate/Polyhydroxybutyrate-Co-Hydroxyvalerate Fiber Mesh
A. Zonari (2012)
10.1089/TEN.TEB.2013.0103
Bladder Acellular Matrix and Its Application in Bladder Augmentation
SongLujie (2014)
10.4995/Thesis/10251/14576
HYALURONAN BASED BIOMATERIALS FOR CENTRAL NERVOUS TISSUE REGENERATION
Baiget Orts (2012)
10.1002/JOR.20352
Long‐bone critical‐size defects treated with tissue‐engineered grafts: A study on sheep
V. Viateau (2007)
10.1002/jbm.a.31982
In vitro and in vivo evaluation of acellular diaphragmatic matrices seeded with muscle precursors cells and coated with VEGF silica gels to repair muscle defect of the diaphragm.
M. Conconi (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar